OraSure Technologies to Present at UBS Global Life Sciences Conference

BETHLEHEM, Pa.--(BUSINESS WIRE)--Sept. 21, 2004--OraSure Technologies, Inc. (Nasdaq NM:OSUR) today announced that Douglas A. Michels, President and Chief Executive Officer, will speak to the investment community at the UBS Global Life Sciences Conference in New York City. The conference will be simultaneously webcast over the Internet.

Mr. Michels is scheduled to speak on September 28, 2004, at approximately 12:00 P.M. Eastern Time (9:00 am Pacific Time). Interested investors can access the live audio webcast of the presentation via the www.ibb.ubs.com web site by clicking on the Conference link in the middle of the page. A replay of the audio webcast will be available until October 30, 2004, on UBS' web site.

About OraSure Technologies

OraSure Technologies develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities.

OraSure Technologies is the leading supplier of oral-fluid collection devices and assays to the life insurance industry and public health markets for the detection of antibodies to HIV-1. In addition, the Company supplies oral-fluid testing solutions for drugs of abuse testing. For more information on the Company, please go to www.orasure.com.

    CONTACT: OraSure Technologies, Inc.
             Ronald H. Spair, 610-882-1820
             Investorinfo@orasure.com
             www.orasure.com

    SOURCE: OraSure Technologies, Inc.